The heart has two upper chambers, the atria, and two lower chambers, the ventricles. In a usual heartbeat an electrical impulse starts in the sinoatrial node in the right atrium, spreads through the atria and reaches the atrioventricular, or AV, node. The AV node briefly delays the impulse before specialised pathways carry it to the ventricles. This sequence helps the atria and then the ventricles contract in coordination.

An arrhythmia is a disturbance of the heart’s rhythm. Electrical impulses may arise from an unwanted focus, travel around a circuit repeatedly, or spread in a disorganised way. The result can be a fast, slow or irregular pulse, palpitations, breathlessness, dizziness or no obvious symptoms. The particular rhythm and its origin matter: a treatment that interrupts one circuit may not treat another.

A catheter is a thin flexible tube passed through a blood vessel into the heart. An electrophysiologist, a heart rhythm specialist, uses catheters to record electrical signals and identify or target tissue involved in the rhythm. Ablation applies energy to create carefully placed areas of altered tissue or scar so a trigger or unwanted circuit cannot conduct in the same way. It does not open a blocked coronary artery or replace a valve.

Atrial fibrillation, or AF, involves disorganised electrical activity in the atria. The AV node receives many impulses and the ventricles often beat irregularly. AF can make the heart less efficient and allow blood to pool in the atria, increasing the risk of clot and stroke in some people. Symptoms and stroke risk are separate questions: a person can have little awareness of AF but still need a stroke-prevention assessment.

Paroxysmal AF starts and stops on its own, usually within seven days. Persistent AF is sustained beyond seven days. The term permanent AF is used when a decision has been made not to pursue restoration of sinus rhythm. These terms describe patterns and treatment decisions; an individual can move between categories. The suitability and expected result of ablation depend on the type, duration and other health factors.

Atrial flutter is a different rhythm, usually driven by a repeating circuit in the atrium. Typical flutter often uses a predictable circuit in the right atrium; atypical flutter uses a different circuit and may require more detailed mapping. AF and flutter can occur in the same person. Supraventricular tachycardia, or SVT, describes fast rhythms arising above the ventricles and includes several distinct mechanisms, such as a circuit using the AV node or an extra pathway.

Ventricular tachycardia, or VT, starts in the ventricles. It can be serious, particularly in a damaged heart, and may require an emergency plan. VT ablation may be offered to reduce recurrent episodes or shocks from an implantable cardioverter defibrillator, an ICD. It does not automatically replace an ICD or other treatment. The assessment, benefits and risks for VT differ from those for AF or a typical SVT.

A description of symptoms is useful, but an electrocardiogram, or ECG, records the electrical rhythm and helps identify what is happening. If episodes come and go, a longer ambulatory monitor or event recorder may capture a rhythm missed on a standard ECG. Clinicians can also consider blood tests, an echocardiogram or other investigations according to the situation. Bring any previous ECGs or recordings and note when symptoms occur.

An electrophysiology study uses catheters to record signals inside the heart and may use controlled electrical stimulation to bring on a rhythm so its mechanism can be mapped. Some rhythm problems can be ablated in the same session; occasionally the rhythm cannot be induced or the findings change the plan. Ask whether a diagnostic study and treatment are both planned and what happens if the target cannot be safely reached.

The choice depends on the rhythm, its effect on you, the chance of recurrence, your heart structure and function, other conditions, previous treatment and your preferences. NICE recommends considering left atrial catheter ablation for symptomatic paroxysmal or persistent AF when drug treatment has been unsuccessful, is unsuitable or is not tolerated. Specialist teams may discuss ablation in other circumstances using current evidence and individual judgement.

Ablation can be used for some other symptomatic or potentially dangerous arrhythmias when the expected benefit outweighs the risk. A particular SVT circuit may be a different decision from persistent AF, and VT with impaired heart function needs its own specialist assessment. Ask what the procedure is intended to improve for you: symptoms, rhythm episodes, shocks or another outcome.

Depending on the rhythm, reasonable options may include monitoring, medicines, an electrical cardioversion or catheter ablation. For AF, rate-control medicines such as a beta blocker slow the ventricular response without necessarily restoring sinus rhythm; rhythm-control medicines such as flecainide or amiodarone aim to restore or maintain it. The choice depends on heart disease and other individual factors. Electrical cardioversion uses a controlled shock under sedation or anaesthesia to restore a regular rhythm, but AF can return. Your team can explain which options apply to your diagnosis.

Medicines can reduce symptoms or episodes but can also cause side effects and may be unsuitable with some heart conditions or other medicines. A successful ablation may allow some rhythm medicines to be reduced later, but a procedure does not guarantee freedom from medication. Discuss what happens if you continue your current treatment, try another medicine, postpone a procedure or have no immediate intervention.

A different treatment, AV-node ablation with permanent pacing, may be considered for selected people whose AF symptoms remain problematic despite other treatments. It deliberately interrupts conduction from the atria to the ventricles and requires a pacemaker to maintain the ventricular heartbeat. It does not eliminate AF in the atria; stroke prevention remains a separate decision. This planned dependence on pacing is distinct from the uncommon unintended need for a pacemaker after damage to normal conduction during another ablation.

Ablation can be an initial rhythm-control option in selected patients. In the EARLY-AF randomised trial, 303 adults with symptomatic paroxysmal AF were assigned to initial cryoballoon ablation or antiarrhythmic drugs and followed with continuous monitoring. Atrial tachyarrhythmia recurrence between day 91 and one year occurred in 66 of 154 people assigned ablation and 101 of 149 assigned drugs. Serious adverse events were reported in five people in the ablation group and six in the drug group. The open-label trial involved a selected group and public and unrestricted industry funding. The result is not a universal success rate and does not establish the result for persistent AF, flutter or VT.

AF can lead to clots, particularly in the left atrium, that may travel to the brain and cause a stroke. Anticoagulants reduce clot formation; they are not the same as medicines used to slow the pulse or maintain a regular rhythm. The need for anticoagulation depends on an assessment of stroke and bleeding risks and individual circumstances. The team also looks for ways to reduce avoidable bleeding risks.

For left atrial ablation, the team gives an individual plan for anticoagulants before, during and after the procedure. Depending on your medicine and circumstances, doses may be continued or handled in a particular way around the procedure. If you take warfarin, INR checks help assess its effect. Report missed doses promptly and follow the hospital’s instructions. Never stop, restart or change a blood thinner on your own because the wrong timing can increase clot or bleeding risk.

A person may feel better after AF ablation or have no AF detected on a particular recording, yet still have a continuing risk of AF and stroke. NICE advises not stopping anticoagulation solely because AF is no longer detectable; the decision should be based on reassessment of stroke and bleeding risk and discussion of preferences. Ask who will review the plan and when. The same distinction matters if an AV-node ablation and pacemaker control the pulse but AF remains in the atria.

Pre-assessment covers your symptoms, health conditions, allergies, previous anaesthetics, medicines and any devices such as a pacemaker or ICD. Include prescribed and non-prescription medicines, vitamins and supplements. Follow the team’s written instructions for eating, drinking and each medicine, including anticoagulants and antiarrhythmics. Some instructions are specific to the rhythm being investigated; if unclear, contact the team instead of guessing.

For some AF procedures the team may arrange imaging or a transoesophageal echocardiogram to check for a clot in the heart. The plan can change or be delayed if a clot is found or anticoagulation has not been taken as instructed. Tell the team about missed anticoagulant doses, a new illness, infection or a possible pregnancy. Ask which tests you need and what would cause a postponement.

Ask whether your procedure uses sedation or general anaesthesia, whether you are likely to stay overnight, and who should take you home. Arrange support for the first day and obtain a contact number for concerns. Informed consent includes the proposed benefit, material risks and reasonable alternatives. You can ask questions and change your mind before treatment.

In a specialist laboratory, staff monitor your heart rhythm, blood pressure and oxygen. Sedation or a general anaesthetic is used depending on the procedure and centre, with local anaesthetic at the puncture site. Catheters are usually passed through veins at the top of the leg; the team may use other access routes when appropriate. Imaging and electrical mapping guide the catheters, so no open chest incision is normally needed.

The team records signals and may pace the heart to locate the abnormal circuit or focus. For AF ablation the catheters are commonly taken from the right atrium across the wall between the atria into the left atrium. A central aim is often pulmonary vein isolation: making a line of ablation around the pulmonary vein openings to interrupt electrical triggers reaching the atrium. The exact lesion pattern depends on the rhythm and clinical plan.

Radiofrequency ablation uses heat to create small lesions. Cryoablation uses extreme cold, sometimes delivered with a balloon, and pulsed-field ablation uses electrical pulses. The technique and equipment depend on the target rhythm, hospital and individual anatomy. These methods are not interchangeable for every patient; ask why a particular approach is recommended and what alternatives are available in your centre.

The team checks the effect using electrical recordings. At the end, the catheters are removed and pressure or a closure method is used at the puncture sites. The time in the laboratory and recovery area varies with the complexity of mapping, anaesthesia and the rhythm. The electrophysiologist can explain what was found, what was treated and whether the intended electrical result was achieved.

The intended benefit is to reduce or stop the targeted rhythm, relieve symptoms and improve day-to-day life. Results vary with the rhythm, its duration, heart structure, other health conditions and whether one or more procedures are needed. An apparently successful electrical result in the laboratory does not guarantee that an arrhythmia will never return. Ask your centre for figures specific to your diagnosis and how it measures success.

Bruising and bleeding at the vessel entry site are common; a larger collection of blood, vessel damage or infection can need further treatment. The catheter or treatment can also damage the heart wall, causing fluid or blood to collect around the heart, known as tamponade, which may require drainage or emergency treatment. Clot, stroke or transient ischaemic attack, heart attack and death are uncommon but serious possibilities. Individual risks depend on the procedure and your health.

Ablation close to the normal conduction system can accidentally cause heart block, sometimes requiring a pacemaker. Injury to the phrenic nerve can affect movement of the diaphragm and breathing. After AF ablation, narrowing of a pulmonary vein or rare injury to the oesophagus may occur; some complications can present after discharge. Anaesthesia or sedation carries its own risks. Ask which complications are relevant to the proposed target and how your team detects and treats them.

It may not be possible to induce or safely ablate the arrhythmia, and a new or recurrent rhythm can require medicines, cardioversion or another procedure. Risks and outcomes reported in patient leaflets are averages from particular groups and techniques. Compare like with like: the rhythm treated, the follow-up period and whether the result means fewer symptoms, no recorded episodes or no further treatment.

Afterwards staff monitor your pulse, blood pressure, rhythm and puncture site. You may need to lie flat for several hours to reduce bleeding. Some people go home the same day and others stay overnight, depending on their treatment and recovery. Before leaving, ask for the procedure result, medicine list, wound instructions, follow-up plan and a contact number for problems.

Some bruising or a small lump at the groin and temporary tiredness or discomfort can occur. Follow your own discharge instructions on bathing, activity and lifting. Guy’s and St Thomas’ advises its AF ablation patients to avoid heavy lifting and strenuous activity for two weeks; other procedures and individual circumstances can require different advice. Worsening pain, redness or swelling needs clinical review, and continuous bleeding is an emergency.

After sedation or general anaesthesia, arrange an adult to take you home and follow the hospital’s advice about supervision, alcohol and important decisions for the first 24 hours. Ask when you can return to work, exercise and sex, especially if your job is physical. Do not judge a new severe symptom as normal recovery: use the urgent guidance at the start of this guide.

For Great Britain, GOV.UK says car and motorcycle drivers must stop driving for four weeks after ablation for ventricular tachycardia with impaired ventricular function, or after ablation for congenital heart disease, even if it has been corrected. For other reasons the minimum is two days. Bus, coach and lorry drivers must stop for three months and notify DVLA after ablation for VT due to impaired ventricular function or for congenital heart disease; for other reasons the minimum is two weeks. Other medical restrictions may apply. Northern Ireland has separate licensing arrangements. Ask your team and licensing authority about your situation and check with your insurer.

After AF ablation, irregular beats or episodes can occur during the early healing or “blanking” period. Guy’s and St Thomas’ describes the first three months this way. An early episode does not by itself prove that the procedure has failed, but it should not be ignored if prolonged, troublesome or accompanied by emergency symptoms. Your team may ask for an ECG during an episode and advise whether medicines or cardioversion are needed.

Follow-up may include a symptom review, ECG or a wearable heart monitor for a specified period. A short recording may miss intermittent episodes, and symptoms alone cannot prove whether a rhythm has returned. Keep a note of episode times, duration and symptoms, and share any ECG recordings with the team. Ask whom to contact if an appointment is delayed or a recurrence develops.

AF or another treated rhythm can recur months or years later. Options may include further monitoring, a change in medicines, cardioversion or repeat ablation, depending on the rhythm and your priorities. A repeat procedure is a separate decision with its own possible benefits and risks. Continue all medicines until your clinician gives a specific change, particularly anticoagulants.

Other conditions and habits may influence AF recurrence and heart health. Discuss management of blood pressure, weight, sleep-related breathing problems, smoking, alcohol and activity with your care team where relevant. These measures support care but do not replace an assessment of new symptoms or a prescribed stroke-prevention plan.